Notice Number: NOT-CA-18-025
Key Dates
Release Date: November 30, 2017
Issued by
National Cancer Institute (NCI)
Purpose
This Notice corrects the Title of RFA-CA-18-004 "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)".
Funding Opportunity Title
Currently reads:
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
Should correctly read:
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Tony Dickherber, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-547-9980
Email: dickherberaj@mail.nih.gov
Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov